Sartorius Stedim Biotech S.A. SDMHF
OTC PK
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | 106.16M | 55.06M | 77.74M | 90.08M | |
| Total Depreciation and Amortization | 90.64M | 36.79M | 88.41M | 81.45M | |
| Total Amortization of Deferred Charges | -- | 60.88M | -- | -- | |
| Total Other Non-Cash Items | 19.86M | 65.07M | 40.18M | -8.94M | |
| Change in Net Operating Assets | -47.83M | 69.15M | -64.58M | -36.52M | |
| Cash from Operations | 168.84M | 286.95M | 141.75M | 126.07M | |
| Capital Expenditure | -83.11M | -136.32M | -86.14M | -68.72M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -1.98M | -1.13M | -- | |
| Cash from Investing | -83.11M | -138.29M | -87.28M | -68.72M | |
| Total Debt Issued | 294.80M | 400.00K | 12.90M | -- | |
| Total Debt Repaid | -535.60M | 0.00 | 0.00 | -13.70M | |
| Issuance of Common Stock | 2.40M | 4.20M | 1.10M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -2.00M | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -76.60M | 0.00 | -76.15M | -- | |
| Other Financing Activities | -89.10M | -3.70M | -200.00K | -9.90M | |
| Cash from Financing | -450.46M | 1.05M | -60.49M | -26.94M | |
| Foreign Exchange rate Adjustments | 2.51M | -1.40M | -3.40M | -315.70K | |
| Miscellaneous Cash Flow Adjustments | -114.20K | -- | -113.50K | 105.20K | |
| Net Change in Cash | -362.33M | 148.31M | -9.53M | 30.20M | |